Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Allied Supreme Corp. (4770.TW)
Taipei, HSZ, TW
Allied Supreme Corp., together with its subsidiaries, manufactures and sells fluoropolymer resin in China, America, and Taiwan. The company offers fluoropolymer materials, lining products, and coatings; customized products, such as injection molding products, overflow sink/tank, PTFE micro-powders, and PTFE compounds; and solutions for semiconductor, flat panel display, solar, pharmaceutical, biochemical, petrochemical, and traditional chemical industries. It also provides fluoropolymer lining, such sheet lining, iso container, immersion coil and shell and tube type heat exchanger; chemical filter housing; lined pipe and fittings; flexible hose and fluoropolymer coating. It serves the semiconductor, panel, and petrochemical industries. Allied Supreme Corp. was founded in 1981 and is headquartered in Taipei, Taiwan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.96% | +0.00% | -0.43% | -5.73% | -0.43% | -0.22% | -2.74% | -16.79% | +4.30% | +93.70% | +93.70% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | -2 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-26.8% Q1'26: +9.6% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-52.8% Q1'26: -2.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+32.2% Q1'26: +33.3% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+21.2% ★ Q1'26: +19.9% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+17.7% ★ Q1'26: +15.9% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.5% ★ Q1'26: -0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.40× ★ Q1'26: 0.57× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
3.83B
est: 3.71B (+3.4%)
|
6.14B
est: 5.73B (+7.1%)
|
5.69B
est: 5.69B (+0.0%)
|
6.46B
est: 6.49B (-0.5%)
|
4.73B
est: 4.65B (+1.6%)
|
6.01B
5.46B – 6.55B
+29.1% YoY
|
6.56B
5.96B – 7.16B
+9.2% YoY
|
| EBITDA |
1.29B
est: 1.29B (+0.2%)
|
2.30B
est: 1.99B (+15.8%)
|
2.25B
est: 1.98B (+14.1%)
|
2.33B
est: 2.23B (+4.2%)
|
1.20B
est: 1.60B (-25.1%)
|
2.07B
1.88B – 2.26B
+29.1% YoY
|
2.26B
2.05B – 2.47B
+9.2% YoY
|
| EBIT |
1.19B
est: 1.19B (-0.1%)
|
2.19B
est: 1.84B (+18.7%)
|
2.09B
est: 1.83B (+14.1%)
|
2.14B
est: 2.05B (+4.6%)
|
1.00B
est: 1.47B (-31.7%)
|
1.89B
1.72B – 2.07B
+29.1% YoY
|
2.07B
1.88B – 2.26B
+9.2% YoY
|
| Net Income |
966.30M
est: 991.14M (-2.5%)
|
1.78B
est: 1.65B (+7.5%)
|
1.68B
est: 1.70B (-0.8%)
|
1.73B
est: 1.75B (-0.7%)
|
815.86M
est: 815.86M (+0.0%)
|
1.22B
982.73M – 1.57B
+48.9% YoY
|
1.35B
1.19B – 1.51B
+10.7% YoY
|
| SGA |
357.73M
est: 321.25M (+11.4%)
|
480.56M
est: 496.68M (-3.2%)
|
474.07M
est: 493.37M (-3.9%)
|
518.19M
est: 537.61M (-3.6%)
|
374.53M
est: 385.66M (-2.9%)
|
497.75M
452.26M – 543.24M
+29.1% YoY
|
543.75M
494.05M – 593.44M
+9.2% YoY
|
| EPS |
13.94
est: 12.33 (+13.1%)
|
22.54
est: 20.54 (+9.7%)
|
21.22
est: 21.10 (+0.6%)
|
21.67
est: 21.82 (-0.7%)
|
10.20
est: 11.55 (-11.7%)
|
15.99
12.29 – 19.69
+38.4% YoY
|
16.82
14.82 – 18.82
+5.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.04% | 17.3K | 0.54% |
| 2 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.03% | 222.0K | 0.65% |
| 3 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.03% | 34.4K | 0.42% |
| 4 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.03% | 20.3K | 0.74% |
| 5 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.02% | 67.5K | 0.74% |
| 6 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.02% | 311.7K | 0.58% |
| 7 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.01% | 60.8K | 0.55% |
| 8 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.01% | 61.6K | 0.44% |
| 9 | Dimensional - Emerging Markets Value ETF DFEV | 0.01% | 136.7K | 0.46% |
| 10 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.01% | 20.5K | 0.56% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chi-Fang Lin | Accounting Officer | — | — |
| Chiao-Sheng | Chairman of the Board & GM | — | male |
| Ya-Fang Yin | Finance Officer & Corporate Governance Officer | — | — |
| Yang-Mao Zhao | Deputy General Manager | — | — |
| Yu-Ming Huang | Vice President | — | male |
| Yuan-Chung Lee | COO & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4770.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
